Skip to main content
. 2022 Dec 15;94(4):290–299. doi: 10.1136/jnnp-2022-330175

Table 3.

Number of CD4+ and CD8+ T-cell responders among PwMS at T2 and T3

Stimulation and type of T-cell response evaluation Cytokine produced Responders over total N (%)
T2 19 (100) T3 19 (100) P value*
Spike-specific CD4+ T cells Any Th1 2 (10.5) 5 (26.31) 0.248
IFN-γ 2 (10.5) 5 (26.31) 0.248
TNF-α 2 (10.5) 0 (0) 0.479
IL-2 0 (0) 0 (0) n/a
Spike-specific CD8+ T cells Any Th1 2 (10.5) 2 (10.5) n/a
IFN-γ 1 (5.2) 2 (10.5) >0.9999
TNF-α 1 (5.2) 0 (0) >0.9999
IL-2 0 (0) 0 (0) n/a
CD4+ T cells response to SEB Any Th1 17 (89.5) 19 (100) 0.479
IFN-γ 16 (84.2) 19 (100) 0.248
TNF-α 17 (89.5) 19 (100) 0.479
IL-2 10 (60.1) 5 (26.3) 0.182
CD8+ T cells response to SEB Any Th1 19 (100) 19 (100) n/a
IFN-γ 16 (84.2) 19 (100) 0.248
TNF-α 11 (57.9) 18 (94.7) 0.045
IL-2 11 (57.9) 3 (15.8) 0.026

In bold are indicated the significant values.

*McNemar’s test.

N, Number; n/a, not available; PwMS, Patients with Multiple Sclerosis; SEB, staphylococcal enterotoxin B.